Helen Stephenson-Ellis
Corporate Officer/Principal bei Chartered Institute of Personnel & Development
Aktive Positionen von Helen Stephenson-Ellis
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Chartered Institute of Personnel & Development | Corporate Officer/Principal | - | - |
Karriereverlauf von Helen Stephenson-Ellis
Ehemalige bekannte Positionen von Helen Stephenson-Ellis
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
OXFORD BIOMEDICA PLC | Personalreferent | 03.04.2018 | 01.05.2022 |
VERNALIS | Personalreferent | - | - |
Medimmune UK Ltd.
Medimmune UK Ltd. Chemicals: Major DiversifiedProcess Industries Medimmune UK Ltd. manufactures chemical products. The company was founded on October 6, 1999 and is headquartered in Speke, the United Kingdom. | Personalreferent | - | - |
ASTRAZENECA PLC | Personalreferent | - | - |
Ausbildung von Helen Stephenson-Ellis
University of Northumbria | Undergraduate Degree |
Statistik
International
Vereinigtes Königreich | 7 |
Operativ
Human Resources Officer | 4 |
Undergraduate Degree | 1 |
Corporate Officer/Principal | 1 |
Sektoral
Health Technology | 4 |
Consumer Services | 2 |
Commercial Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 2 |
---|---|
OXFORD BIOMEDICA PLC | Health Technology |
ASTRAZENECA PLC | Health Technology |
Private Unternehmen | 2 |
---|---|
Medimmune UK Ltd.
Medimmune UK Ltd. Chemicals: Major DiversifiedProcess Industries Medimmune UK Ltd. manufactures chemical products. The company was founded on October 6, 1999 and is headquartered in Speke, the United Kingdom. | Process Industries |
Ligand UK Ltd.
Ligand UK Ltd. Pharmaceuticals: MajorHealth Technology Ligand UK Ltd. is a commercial stage pharmaceutical company. Its products include Tuzistra XR, targeting the U.S. prescription cough-cold market, Moxatag, a once-a-day formulation of the antibiotic and amoxicillin, and frovatriptan, used for the acute treatment of migraine. It also develops and commercializes multiple novel products focused on the U.S. prescription cough-cold market. The company was founded by Keith G. McCullagh and Andre L. Lamotte in 1986 and is headquartered in Winnersh, the United Kingdom. | Health Technology |
- Börse
- Insiders
- Helen Stephenson-Ellis
- Erfahrung